Journal of Clinical Lipidology

Papers
(The H4-Index of Journal of Clinical Lipidology is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Comparison of virtual vs face-to-face medical nutrition therapy in patients with hyperlipidemia155
Hypercoagulability or coronary artery disease? Polygenic risk score unveils the mystery146
Effective treatment of statin- and ezetimibe-resistant hyperlipidemia in a patient with active membranous nephrotic syndrome using a PCSK9 inhibitor132
Assessment of health disparities in secondary ASCVD risk prevention in the elderly population in Greece74
Healthcare utilization and expenditures among adults with severe hypertriglyceridemia in US clinical practice73
Lipoprotein(a) concentrations across a global cross-sectional registry70
Disparities in statin use among individuals with and without cancer history across atherosclerotic cardiovascular disease risk categories59
Genetic mutations and associated phenotypes in familial hypercholesterolemia: A biobank study55
Lower Activity of Cholesteryl Ester Transfer protein (CETP) and the Risk of Dementia: A Mendelian Randomization Analysis54
†Role of DNA methylation on 15-Lipoxygenase-1 gene expression in Osteoarthritis54
Care of youth with lipid disorders: A brief provider survey54
Mesenchymal Stromal Cell (MSC) Therapy Improve Nonalcoholic Fatty Liver Disease (NAFLD) in Long Term high Fat Diet (HFD) Induced Obesity (DIO) Mouse50
The Effect of Estrogen and Testosterone on Cholesterol Crystallization48
Socioeconomic Disparities in Dyslipidemia and Associated Complications: From the Latest National Database46
Relation of red blood cell distribution width to risk of major adverse cardiovascular events, death, and effect of alirocumab after acute coronary syndromes44
Genetic Testing for Hypertriglyceridemia in Academic Lipid Clinics - Implications for Precision Medicine40
Impact of providing genetics-based future cardiovascular risk on LDL-C in patients with familial hypercholesterolemia38
News from NLA38
From the Editors: New insights into lipid disorders in children and adolescents as well as cardiovascular benefits of pharmacotherapy for weight loss36
Intima-media thickness in treated and untreated patients with and without familial hypercholesterolemia: A systematic review and meta-analysis34
Prevalence of Lipoprotein(a) Measurements in Patients with or at Risk of Cardiovascular Disease31
Evidence of Direct Hepatic Secretion of Low density Lipoprotein (LDL) in Mice30
Niacin (Niacin) and clinical utility, don't be misled by recent niacin (Niacin) metabolite report28
Lipoprotein(a) levels in children with homozygous familial hypercholesterolaemia: A cross-sectional study28
Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid Association28
Association of Lipoprotein(a) with peri-coronary inflammation in persons with and without HIV infection26
Achievement of low-density lipoprotein cholesterol thresholds in very high-risk atherosclerotic cardiovascular disease26
0.090818166732788